| Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer D Öhlund, A Handly-Santana, G Biffi, E Elyada, AS Almeida, ... Journal of Experimental Medicine 214 (3), 579-596, 2017 | 2238 | 2017 |
| Organoid models of human and mouse ductal pancreatic cancer SF Boj, CI Hwang, LA Baker, IIC Chio, DD Engle, V Corbo, M Jager, ... Cell 160 (1), 324-338, 2015 | 2132 | 2015 |
| Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy MH Sherman, TY Ruth, DD Engle, N Ding, AR Atkins, H Tiriac, ... Cell 159 (1), 80-93, 2014 | 1161 | 2014 |
| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... Cancer discovery 8 (9), 1112-1129, 2018 | 945 | 2018 |
| CDPKs CPK6 and CPK3 Function in ABA Regulation of Guard Cell S-Type Anion- and Ca2+- Permeable Channels and Stomatal Closure IC Mori, Y Murata, Y Yang, S Munemasa, YF Wang, S Andreoli, H Tiriac, ... PLoS biology 4 (10), e327, 2006 | 720 | 2006 |
| Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution M Chan-Seng-Yue, JC Kim, GW Wilson, K Ng, EF Figueroa, GM O’Kane, ... Nature genetics 52 (2), 231-240, 2020 | 545 | 2020 |
| Enhancer reprogramming promotes pancreatic cancer metastasis JS Roe, CI Hwang, TDD Somerville, JP Milazzo, EJ Lee, B Da Silva, ... Cell 170 (5), 875-888. e20, 2017 | 436 | 2017 |
| NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer IIC Chio, SM Jafarnejad, M Ponz-Sarvise, Y Park, K Rivera, W Palm, ... Cell 166 (4), 963-976, 2016 | 378 | 2016 |
| Modeling pancreatic cancer with organoids LA Baker, H Tiriac, H Clevers, DA Tuveson Trends in cancer 2 (4), 176-190, 2016 | 252 | 2016 |
| The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice DD Engle, H Tiriac, KD Rivera, A Pommier, S Whalen, TE Oni, B Alagesan, ... Science 364 (6446), 1156-1162, 2019 | 242 | 2019 |
| TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma TDD Somerville, Y Xu, K Miyabayashi, H Tiriac, CR Cleary, D Maia-Silva, ... Cell reports 25 (7), 1741-1755. e7, 2018 | 208 | 2018 |
| Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment H Tiriac, JC Bucobo, D Tzimas, S Grewel, JF Lacomb, LM Rowehl, ... Gastrointestinal endoscopy 87 (6), 1474-1480, 2018 | 172 | 2018 |
| Advanced development of primary pancreatic organoid tumor models for high-throughput phenotypic drug screening S Hou, H Tiriac, BP Sridharan, L Scampavia, F Madoux, J Seldin, ... SLAS DISCOVERY: Advancing Life Sciences R&D 23 (6), 574-584, 2018 | 157 | 2018 |
| Patient-derived organoid models help define personalized management of gastrointestinal cancer MR Aberle, RA Burkhart, H Tiriac, SWM Olde Damink, CHC Dejong, ... Journal of British Surgery 105 (2), e48-e60, 2018 | 133 | 2018 |
| Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes K Miyabayashi, LA Baker, A Deschênes, B Traub, G Caligiuri, D Plenker, ... Cancer discovery 10 (10), 1566-1589, 2020 | 119 | 2020 |
| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 2018; 8: 1112–1129. doi: 10.1158/2159-8290 H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... CD-18-0349.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 93 | |
| Organoid models for translational pancreatic cancer research H Tiriac, D Plenker, LA Baker, DA Tuveson Current opinion in genetics & development 54, 7-11, 2019 | 81 | 2019 |
| Improving natural product research translation: From source to clinical trial BC Sorkin, AJ Kuszak, G Bloss, NK Fukagawa, FA Hoffman, M Jafari, ... The FASEB Journal 34 (1), 41-65, 2020 | 65 | 2020 |
| Identification of resistance pathways specific to malignancy using organoid models of pancreatic cancer M Ponz-Sarvise, V Corbo, H Tiriac, DD Engle, KK Frese, TE Oni, ... Clinical Cancer Research 25 (22), 6742-6755, 2019 | 61 | 2019 |
| Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma KCM Gulay, X Zhang, V Pantazopoulou, J Patel, E Esparza, ... Cancer research 83 (18), 3001-3012, 2023 | 39 | 2023 |